Tumor-associated anemia
Conditions
Interventions
Experimental group:Investigational Product: Blood Tonic for Nourishing the Bone Marrow Pill
Control Group:Iron supplementation is given as needed. Blood transfusion is performed if there are significant signs of hypoxia. Erythropoiesis-stimulating agents (ESAs) such as EPO are administered a
Sponsors
Mianyang City Traditional Chinese Medicine Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Meets the diagnostic criteria of Western medicine and Chinese medicine syndrome; expected survival period =6 months; has not taken other medications for treating anemia before participating in this study; Karnofsky Performance Status (KPS) score =60 points.
Exclusion criteria
Exclusion criteria: Anemia symptoms caused by other diseases, with concurrent other hematological disorders; cases that do not meet the inclusion criteria, or meet the criteria but did not take medication as prescribed, making it impossible to assess efficacy or with incomplete data affecting efficacy judgment; pregnant or breastfeeding women; individuals allergic to the medications used.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Red Blood Cell Count;Hepcidin;Hematocrit;JAK2;Traditional Chinese Medicine Clinical Symptom Scoring; | — |
Secondary
| Measure | Time frame |
|---|---|
| White blood cell count;Platelet Count;Interleukin-6;Tumor Necrosis Factor;Safety Indicator Monitoring;Quality of Life Rating;Past Medical History;Adverse Reaction and Adverse Event;General Condition of the Subjects;Previous treatment and post-enrollment treatment; | — |
Countries
China
Contacts
Public ContactRen Jijun
Mianyang City Traditional Chinese Medicine Hospital
Outcome results
None listed